HUM Humana
Q3 2025 10-Q
Humana (HUM) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Management Discussion & Analysis
- • Revenue $32.6B Q3 2025, up 11.1% YoY from $29.4B; 9M revenue $97.1B up 9.7% YoY from $88.5B
- • Operating margin declined: income from operations $3.5B Q3 2025 vs $3.1B Q3 2024 (13.1% increase YoY but 45.1% decrease in 9M); benefit ratio 91.1% vs 89.9% Q3, operating cost ratio 12.6% vs 11.5% Q3
Risk Factors
- • Section 'risk_factors' was empty or not found.
Quarterly Financial SummaryXBRL
Revenue
$32.6B
▲ +11.1% YoY▲ +0.8% QoQ
Net Income
$195M
▼ -59.4% YoY▼ -64.2% QoQ
Net Margin
0.6%
▼ -104bp YoY▼ -109bp QoQ
Source: XBRL data from Humana Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Humana Quarterly Reports
Get deeper insights on Humana
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.